Effects of alpha-lipoic acid supplementation on cardiometabolic risk factors: A systematic review and dose-response meta-analysis
Nutrition, Metabolism and Cardiovascular Diseases · 2026
DOI: 10.1016/j.numecd.2025.104370 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Shooka Mohammadi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: shooka.mohammadi…. Hauptthemen laut MEDLINE: Thioctic Acid, Cardiometabolic Risk Factors, Metabolic Syndrome, Dietary Supplements. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 160 Literaturangaben.
Abstract (Originalsprache)
AIMS: There is no definitive consensus regarding the impacts of alpha-lipoic acid (ALA) supplementation on the risk factors of cardiometabolic syndrome (CMS). This systematic review and meta-analysis evaluated the effects of ALA supplementation on CMS risk factors. DATA SYNTHESIS: A comprehensive search of several databases identified 63 eligible randomized controlled trials (RCTs) published until May 2025. The meta-analysis revealed that supplementation with ALA substantially decreased homeostatic model assessment for insulin resistance (weighted mean difference (WMD): -0.74, 95 % confidence interval (CI): -1.17, -0.31; P = 0.001), waist circumference (WMD: -1.10 cm, 95 % CI: -1.66, -0.54; P < 0.001), body mass index (WMD: -0.27 kg/m2, 95 % CI: -0.44, -0.10; P = 0.002), fat mass (WMD: -1.42 kg, 95 % CI: -2.53, -0.31; P = 0.012), body weight (WMD: -0.64 kg, 95 % CI: -1.04, -0.24; P = 0.002), serum levels of fasting blood glucose (WMD: -5.28 mg/dL, 95 % CI: -7.21, -3.35; P < 0.001), total cholesterol (WMD: -3.91 mg/dL, 95 % CI: -7.35, -0.46; P = 0.026), hemoglobin A1C (WMD: -0.40 %, 95 % CI: -0.66, -0.14; P = 0.003), triglycerides (WMD: -2.90 mg/dL, 95 % CI: -5.21, -0.59; P = 0.014), and fasting insulin (WMD: -1.70 mU/mL, 95 % CI: -2.88, -0.53; P = 0.004) in the ALA group compared with the control group. However, no substantial effect of ALA was identified on low-density lipoprotein cholesterol, blood pressure, and high-density lipoprotein cholesterol. CONCLUSIONS: ALA supplementation may improve certain cardiometabolic risk factors by ameliorating anthropometric and glycemic parameters, as well as through its potential lipid-lowering effects. PROSPERO REGISTRATION: CRD420251038360.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: shooka.mohammadi@gmail.com.
- Nutrition and Metabolic Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Division of Cardiovascular Medicine, School of Medicine, University of Louisville, Louisville, KY, USA.
- Department of Pediatric Cardiology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Internal Medicine, Faculty of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
- Department of Internal Medicine, Mercy San Juan Medical Center, Carmichael, CA, USA.
Zitieren
APA
Mohammadi, S., Ashtary-Larky, D., Alaghemand, N., Alavi, I., Erfanian-Salim, M., Pirayvatlou, P. S., Ettehad, Y., Borzabadi, A., Mehrbod, M., & Asbaghi, O. (2026). Effects of alpha-lipoic acid supplementation on cardiometabolic risk factors: A systematic review and dose-response meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104370
Vancouver
Mohammadi S, Ashtary-Larky D, Alaghemand N, Alavi I, Erfanian-Salim M, Pirayvatlou PS, et al. Effects of alpha-lipoic acid supplementation on cardiometabolic risk factors: A systematic review and dose-response meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2025.104370
BibTeX
@article{Mohammadi2026,
author = {Mohammadi, Shooka and Ashtary-Larky, Damoon and Alaghemand, Navid and Alavi, Ilnaz and Erfanian-Salim, Mahsa and Pirayvatlou, Pouyan Sanjari and Ettehad, Yeganeh and Borzabadi, Aida and Mehrbod, Milad and Asbaghi, Omid},
title = {Effects of alpha-lipoic acid supplementation on cardiometabolic risk factors: A systematic review and dose-response meta-analysis},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.numecd.2025.104370}
}
EUVIMED